Compare SNCR & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNCR | NEPH |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 60.0M |
| IPO Year | 2006 | 2004 |
| Metric | SNCR | NEPH |
|---|---|---|
| Price | $8.54 | $5.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 278.6K | 75.2K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | ★ $170,909,000.00 | $17,930,000.00 |
| Revenue This Year | $0.30 | $33.32 |
| Revenue Next Year | $5.43 | $12.27 |
| P/E Ratio | ★ N/A | $36.15 |
| Revenue Growth | 0.07 | ★ 32.36 |
| 52 Week Low | $3.98 | $1.39 |
| 52 Week High | $12.85 | $6.42 |
| Indicator | SNCR | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 78.10 | 48.33 |
| Support Level | $8.45 | $4.83 |
| Resistance Level | $8.60 | $5.97 |
| Average True Range (ATR) | 0.25 | 0.63 |
| MACD | 0.37 | -0.03 |
| Stochastic Oscillator | 92.33 | 28.93 |
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.